PhaSeal protects cancer drug handlers
A closed system that prevents the exposure of healthcare workers to hazardous anticancer drugs, developed by Sweden's Carmel Pharma, has been introduced in the USA by Baxa.
A closed system that prevents the exposure of healthcare workers to hazardous anticancer drugs, developed by Sweden's Carmel Pharma, has been introduced in the USA by Baxa.
Italian drug delivery specialist Eurand has made a foray into the market for fast-melt oral tablets that dissolve quickly in the mouth without chewing or the need for water.
The US Consumer Product Safety Commission has started a review of its criteria to determine whether drug packages meet its child-resistance standards.
A new formulation of GlaxoSmithKline's Parkinson's disease drug Requip (ropinirole), developed with UK drug delivery specialist SkyePharma, has entered Phase III testing.
France's Diatos has moved into a new 800m2 office and laboratory space in Paris Biopark, more than double the size of the firm's current facilities.
Novo Nordisk has sent out the first batch of bulk insulin from a new facility at its site in Kalundborg, Denmark, that is producing more than a third of the world's supply.